Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
Go back to Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study| (NASDAQ: EDSA) | Delayed: 7.64 +0.83 (12.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.81 | 52 Week High | $ | |||
| Open | $6.69 | 52 Week Low | $ | |||
| Day High | $7.65 | P/E | N/A | |||
| Day Low | $6.60 | EPS | $ | |||
| Volume | 123,276 | |||||
